Syndax Pharmaceuticals/$SNDX
About Syndax Pharmaceuticals
Ticker
Industry
Employees
SNDX Metrics
$1.1B
-
-$3.62
0.92
-
Price and volume
Market cap
$1.1B
Beta
0.92
52-week high
$25.34
52-week low
$12.40
Average daily volume
2.4M
Financial strength
Current ratio
6.986
Quick ratio
6.923
Long term debt to equity
0.001
Total debt to equity
0.233
Interest coverage (TTM)
-1,726.95%
Management effectiveness
Return on assets (TTM)
-48.67%
Return on equity (TTM)
-81.88%
Valuation
Price to revenue (TTM)
65.694
Price to book
2.99
Price to tangible book (TTM)
2.99
Price to free cash flow (TTM)
-4.06
Growth
Earnings per share change (TTM)
39.84%
3-year revenue growth (CAGR)
5.80%
3-year earnings per share growth (CAGR)
25.59%
What the Analysts think about SNDX
Analyst Ratings
SNDX Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
SNDX Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
SNDX News
FAQs
What’s the current market cap for Syndax Pharmaceuticals stock?
What is the P/E ratio for Syndax Pharmaceuticals stock?
Does Syndax Pharmaceuticals stock pay dividends?
No, Syndax Pharmaceuticals (SNDX) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Syndax Pharmaceuticals dividend payment date?
Syndax Pharmaceuticals (SNDX) stock does not pay dividends to its shareholders.
What is the beta indicator for Syndax Pharmaceuticals?
Syndax Pharmaceuticals (SNDX) has a beta rating of 0.92. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.